Related references
Note: Only part of the references are listed.LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance
Melyssa S. Roberts et al.
CANCER RESEARCH (2020)
Tau acetylates and stabilizes β-catenin thereby promoting cell survival
Enjie Liu et al.
EMBO REPORTS (2020)
Block of proliferation 1 promotes cell migration and invasion in human colorectal cancer cells via the JNK pathway
Xiaoxi Chen et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2020)
Bcl-3 promotes Wnt signaling by maintaining the acetylation of β-catenin at lysine 49 in colorectal cancer
Xi Chen et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Chromosome 12p Amplification in Triple-Negative/BRCA1-Mutated Breast Cancer Associates with Emergence of Docetaxel Resistance and Carboplatin Sensitivity
Jorge Gomez-Miragaya et al.
CANCER RESEARCH (2019)
TUFT1 Promotes Triple Negative Breast Cancer Metastasis, Stemness, and Chemoresistance by Up-Regulating the Rac1/β-Catenin Pathway
Weiguang Liu et al.
FRONTIERS IN ONCOLOGY (2019)
CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer
Lei Nie et al.
NATURE COMMUNICATIONS (2019)
Loss of RBMS3 Confers Platinum Resistance in Epithelial Ovarian Cancer via Activation of miR-126-5p/β-catenin/CBP signaling
Geyan Wu et al.
CLINICAL CANCER RESEARCH (2019)
Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
Nithya Krishnamurthy et al.
CANCER TREATMENT REVIEWS (2018)
Time-Resolved Analysis Reveals Rapid Dynamics and Broad Scope of the CBP/p300 Acetylome
Brian T. Weinert et al.
CELL (2018)
Preferential Inhibition of Wnt/-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer
Abhishek Gangrade et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer
Alexander Ring et al.
CANCERS (2018)
NOR1 Suppresses Cancer Stem-Like Cells Properties of Tumor Cells via the Inhibition of the AKT-GSK-3β-Wnt/β-catenin-ALDH1A1 Signal Circuit
Wei Wang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling
Peng Han et al.
MOLECULAR CANCER (2017)
Trimethylation and Acetylation of β-Catenin at Lysine 49 Represent Key Elements in ESC Pluripotency
Katrin Hoffmeyer et al.
CELL REPORTS (2017)
Activated Thyroid Hormone Promotes Differentiation and Chemotherapeutic Sensitization of Colorectal Cancer Stem Cells by Regulating Wnt and BMP4 Signaling
Veronica Catalano et al.
CANCER RESEARCH (2016)
New Wnt/β-catenin target genes promote experimental metastasis and migration of colorectal cancer cells through different signals
Jingjing Qi et al.
GUT (2016)
RECQL4 helicase has oncogenic potential in sporadic breast cancers
Arvind Arora et al.
JOURNAL OF PATHOLOGY (2016)
Pygo2 activates MDR1 expression and mediates chemoresistance in breast cancer via the Wnt/β-catenin pathway
Z-M Zhang et al.
ONCOGENE (2016)
Aldehyde Dehydrogenase Is Regulated by β-Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells
Monica Cojoc et al.
CANCER RESEARCH (2015)
Molecularly targeted therapies for metastatic triple-negative breast cancer
Soley Bayraktar et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
SIRT1 regulates differentiation of mesenchymal stem cells by deacetylating β-catenin
Petra Simic et al.
EMBO MOLECULAR MEDICINE (2013)
The Wnt/β-catenin pathway in ovarian cancer: A review
Rebecca C. Arend et al.
GYNECOLOGIC ONCOLOGY (2013)
Neoadjuvant treatments for triple-negative breast cancer (TNBC)
G. von Minckwitz et al.
ANNALS OF ONCOLOGY (2012)
Methylation of Cancer-Stem-Cell-Associated Wnt Target Genes Predicts Poor Prognosis in Colorectal Cancer Patients
Felipe de Sousa e Melo et al.
CELL STEM CELL (2011)
Block of Proliferation 1 (BOP1) Plays an Oncogenic Role in Hepatocellular Carcinoma by Promoting Epithelial-to-Mesenchymal Transition
Kit-Ying Chung et al.
HEPATOLOGY (2011)
Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists
Sunil Badve et al.
MODERN PATHOLOGY (2011)
Gene expression meta-analysis identifies chromosomal regions and candidate genes involved in breast cancer metastasis
Mads Thomassen et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
Bryan T. MacDonald et al.
DEVELOPMENTAL CELL (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
Chad J. Creighton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
Cornelia Liedtke et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Triple negative tumours: a critical review
J. S. Reis-Filho et al.
HISTOPATHOLOGY (2008)
The CD44(+)/CD24(-) phenotype is enriched in basal-like breast tumors
Gabriella Honeth et al.
BREAST CANCER RESEARCH (2008)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
Interdependence of Pes1, Bop1, and WDR12 controls nucleolar localization and assembly of the PeBoW complex required for maturation of the 60S ribosomal subunit
Michaela Rohrmoser et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Descriptive analysis of estrogen receptor (ER)negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype - A population-based study from the California Cancer Registry
Katrina R. Bauer et al.
CANCER (2007)
Contribution of the BOP1 gene, located on 8q24, to colorectal tumorigenesis
Audrey Killian et al.
GENES CHROMOSOMES & CANCER (2006)
The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells
M van de Wetering et al.
CELL (2002)
Functional inactivation of the mouse nucleolar protein bop1 inhibits multiple steps in pre-rRNA processing and blocks cell cycle progression
Z Strezoska et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Drug resistance in cancer: A perspective
JH Goldie
CANCER AND METASTASIS REVIEWS (2001)
Bop1 is a mouse WD40 repeat nucleolar protein involved in 28S and 5.8S rRNA processing and 60S ribosome biogenesis
Z Strezoska et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
The p300/CBP acetyltransferases function as transcriptional coactivators of β-catenin in vertebrates
A Hecht et al.
EMBO JOURNAL (2000)
The transcriptional coactivator CBP interacts with β-catenin to activate gene expression
KI Takemaru et al.
JOURNAL OF CELL BIOLOGY (2000)
Share Paper
